Phaseline

Targets › CGB

CGB: drug programs, companies and trials

2 programs from 2 companies in 2 trials: 1 Phase 3, 1 Phase 4; Genitourinary; next expected readout Dec 2027.

Open in Phaseline: the race on CGB, likelihood bands and readouts

Programs

CompanyDrugTargetsHighest phaseConditionsNext expected readout
Fertility Center of Las VegashCG injection
human chorionic gonadotropin - luteal phase support
CGA, CGBPhase 4Infertility (IVF Patients)Dec 2027
Kristine LoesslChoriongonadotropin alfa
Human chorionic gonadotropin (hCG) agonist
CGA, CGBPhase 3Infertility, FemaleMar 2028

Conditions

Infertility, Female (1) Infertility (IVF Patients) (1)

Modalities

small molecule (2)

Companies

Kristine Loessl (1) Fertility Center of Las Vegas (1)

Related targets

CGA (2)

Programs group each company's trials by drug; targets and mechanisms come from Open Targets and ChEMBL via Open Targets; expected readouts are Phaseline's estimate from the registry's primary completion date. Facts from the registries only; the approval likelihood is in the app.